BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25683654)

  • 21. Comorbidity associated with atrial fibrillation: a general practice-based study.
    Carroll K; Majeed A
    Br J Gen Pract; 2001 Nov; 51(472):884-6, 889-91. PubMed ID: 11761201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation.
    Indredavik B; Rohweder G; Lydersen S
    J Intern Med; 2005 Aug; 258(2):133-44. PubMed ID: 16018790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anticoagulation in polypathological patients with atrial fibrillation].
    Díez-Manglano J; Bernabeu-Wittel M; Barón-Franco B; Murcia-Zaragoza J; Fuertes Martín A; Alemán A; Ollero-Baturone M;
    Med Clin (Barc); 2013 Feb; 140(3):97-103. PubMed ID: 23199837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.
    Hansen ML; Jepsen RM; Olesen JB; Ruwald MH; Karasoy D; Gislason GH; Hansen J; Køber L; Husted S; Torp-Pedersen C
    Europace; 2015 Jan; 17(1):18-23. PubMed ID: 25231909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
    Audebert HJ; Schenk B; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2010; 29(5):476-83. PubMed ID: 20299787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of comorbidities among patients with atrial fibrillation.
    LaMori JC; Mody SH; Gross HJ; daCosta DiBonaventura M; Patel AA; Schein JR; Nelson WW
    Ther Adv Cardiovasc Dis; 2013 Apr; 7(2):53-62. PubMed ID: 23090783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
    Shroff GR; Solid CA; Herzog CA
    JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
    [No Abstract]   [Full Text] [Related]  

  • 29. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation.
    Hernandez I; Saba S; Zhang Y
    Stroke; 2017 Aug; 48(8):2289-2291. PubMed ID: 28655815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.
    Friberg L; Skeppholm M; Terént A
    J Am Coll Cardiol; 2015 Jan; 65(3):225-32. PubMed ID: 25614418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
    Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
    J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK.
    Han TS; Fry CH; Fluck D; Affley B; Gulli G; Barrett C; Kakar P; Patel T; Sharma S; Sharma P
    BMJ Open; 2018 Jul; 8(7):e022558. PubMed ID: 29997144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?
    Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
    Europace; 2014 Dec; 16(12):1714-9. PubMed ID: 25013011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).
    Ertas F; Eren NK; Kaya H; Aribas A; Acar G; Kanadasi M; Gedik S; Oylumlu M; Yuksel M; Ulgen MS;
    Cardiol J; 2013; 20(4):447-52. PubMed ID: 23677730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.
    Li X; Tse VC; Au-Doung LW; Wong ICK; Chan EW
    Europace; 2017 Jun; 19(6):937-947. PubMed ID: 27209573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.